Interstitial lung disease due to anti-TNF use in the treatment of psoriasis
An. bras. dermatol
;
96(4): 447-450, July-Aug. 2021. graf
Article
in English
| LILACS
| ID: biblio-1285096
ABSTRACT
Abstract Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Psoriasis
/
Lung Diseases, Interstitial
Limits:
Humans
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Universitário Onofre Lopes/BR
Similar
MEDLINE
...
LILACS
LIS